<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Epidemiology and Infectious Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Epidemiology and Infectious Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Эпидемиология и инфекционные болезни</trans-title></trans-title-group></journal-title-group><issn publication-format="print">3034-2007</issn><issn publication-format="electronic">3034-2015</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">516349</article-id><article-id pub-id-type="doi">10.17816/EID516349</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original study articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en"><italic>Streptococcus agalactiae</italic> in asymptomatic bacteriuria in pregnant women</article-title><trans-title-group xml:lang="ru"><trans-title><italic>Streptococcus agalactiae</italic> при бессимптомной бактериурии у беременных</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-2574-6204</contrib-id><contrib-id contrib-id-type="spin">7849-2212</contrib-id><name-alternatives><name xml:lang="en"><surname>Semechkin</surname><given-names>Nikolai V.</given-names></name><name xml:lang="ru"><surname>Семечкин</surname><given-names>Николай Викторович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>Кандидат медицинских наук</p></bio><email>nykolay1@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0006-8092-2647</contrib-id><contrib-id contrib-id-type="spin">1896-8240</contrib-id><name-alternatives><name xml:lang="en"><surname>Romanov</surname><given-names>Vitaly A.</given-names></name><name xml:lang="ru"><surname>Романов</surname><given-names>Виталий Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med), Professor</p></bio><bio xml:lang="ru"><p>доктор медицинских наук, профессор</p></bio><email>mister.bandicut@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0001-8841-6275</contrib-id><name-alternatives><name xml:lang="en"><surname>Danilik</surname><given-names>Oleg N.</given-names></name><name xml:lang="ru"><surname>Данилик</surname><given-names>Олег Николаевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>student</p></bio><bio xml:lang="ru"><p>Студент </p></bio><email>oleg.danilik7@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-4512-8299</contrib-id><contrib-id contrib-id-type="spin">1085-0928</contrib-id><name-alternatives><name xml:lang="en"><surname>Novosadova</surname><given-names>Irina G.</given-names></name><name xml:lang="ru"><surname>Новосадова</surname><given-names>Ирина Григорьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><bio xml:lang="ru"><p>заведующая микробиологической лабораторией</p></bio><email>novosadova@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4691-648X</contrib-id><name-alternatives><name xml:lang="en"><surname>Ershova</surname><given-names>Marina G.</given-names></name><name xml:lang="ru"><surname>Ершова</surname><given-names>Марина Геннадьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><bio xml:lang="ru"><p>Заведующая микробиологической лабораторией</p></bio><email>marierchowa2013@yandex.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Akentyeva</surname><given-names>Svetlana A.</given-names></name><name xml:lang="ru"><surname>Акентьева</surname><given-names>Светлана Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD</p></bio><bio xml:lang="ru"><p>врач микробиологической лаборатории</p></bio><email>lana2500@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Yaroslavl State Medical University</institution></aff><aff><institution xml:lang="ru">Ярославский государственный медицинский университет</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Balashikha Regional Hospital</institution></aff><aff><institution xml:lang="ru">Балашихинская областная больница</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Infectious Clinical Hospital</institution></aff><aff><institution xml:lang="ru">Инфекционная клиническая больница</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2023-10-11" publication-format="electronic"><day>11</day><month>10</month><year>2023</year></pub-date><pub-date date-type="pub" iso-8601-date="2023-11-05" publication-format="electronic"><day>05</day><month>11</month><year>2023</year></pub-date><volume>28</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>289</fpage><lpage>295</lpage><history><date date-type="received" iso-8601-date="2023-06-28"><day>28</day><month>06</month><year>2023</year></date><date date-type="accepted" iso-8601-date="2023-09-05"><day>05</day><month>09</month><year>2023</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2023, Eco-vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2023, Эко-вектор</copyright-statement><copyright-year>2023</copyright-year><copyright-holder xml:lang="en">Eco-vector</copyright-holder><copyright-holder xml:lang="ru">Эко-вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2026-11-05"/></permissions><self-uri xlink:href="https://rjeid.com/1560-9529/article/view/516349">https://rjeid.com/1560-9529/article/view/516349</self-uri><abstract xml:lang="en"><p><bold><italic>BACKGROUND</italic></bold><bold><italic>:</italic></bold> Asymptomatic bacteriuria caused by group B gram-positive streptococcus, <italic>Streptococcus</italic> <italic>agalactiae</italic>, in pregnant women is a leading cause of sepsis in newborns and young children, transmitted from their mothers. In the present study, the frequency of <italic>S</italic><italic>. </italic><italic>agalactiae</italic> inoculation from the urine of pregnant women with asymptomatic bacteriuria was studied with the determination of the sensitivity of isolated strains to antibiotics.</p> <p><bold><italic>AIMS</italic></bold><bold><italic>:</italic></bold> This study aimed to investigate the inoculation of group B streptococcus in asymptomatic bacteriuria of pregnant women and to determine the sensitivity of the isolated cultures of the pathogen to the main antibiotics.</p> <p><bold><italic>MATERIALS</italic></bold> <bold><italic>AND</italic></bold> <bold><italic>METHODS</italic></bold><bold><italic>:</italic></bold> The analysis involved bacteriological studies of 2,559 urine samples collected from pregnant women. Urine was inoculated on UriSelect 4 Medium chromogenic medium with subsequent identification of <italic>S</italic><italic>. </italic><italic>agalactiae</italic> using a strepto-latex test or a CAMP test with a <italic>Staphylococcus</italic> <italic>aureus</italic> culture. The sensitivity of microorganisms to antibacterial drugs was determined using the disk diffusion method. Data analysis was conducted using the Statistica 12.0 software package.</p> <p><bold><italic>RESULTS</italic></bold><bold><italic>:</italic></bold> Out of 2,559 urine samples studied, asymptomatic bacteriuria was detected in 317 samples (12.4%), and 330 strains of microorganisms were isolated. <italic>S</italic><italic>. </italic><italic>agalactiae</italic> was isolated by culture from 108 pregnant women (4.2% of the total subjects), with 50 cases (16%) showing asymptomatic bacteriuria caused by <italic>S</italic><italic>. </italic><italic>agalactiae</italic>. The high significance of <italic>Escherichia</italic> <italic>coli</italic> in asymptomatic bacteriuria in pregnant women was shown, with a lesser extent of involvement observed with <italic>Enterococcus</italic> spp. Furthermore, associations of <italic>S</italic><italic>. </italic><italic>agalactiae</italic> with other microorganisms were identified. The high sensitivity of <italic>S</italic><italic>. </italic><italic>agalactiae</italic> strains to clindamycin, to a lesser extent to levofloxacin, chloramphenicol, and, especially, to erythromycin, has been demonstrated.</p> <p><bold><italic>CONCLUSIONS</italic></bold><bold><italic>:</italic></bold> The study revealed a high culturability of group B streptococcus in asymptomatic bacteriuria in pregnant women. Low sensitivity of isolated streptococci to erythromycin, moderate sensitivity to levofloxacin and chloramphenicol, and high sensitivity to clindamycin were also revealed.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование.</bold> Бессимптомная бактериурия у беременных, вызванная грамположительными стрептококками <italic>Streptococcus</italic> <italic>agalactiae</italic> группы B, является одной из причин сепсиса у новорождённых и детей раннего возраста в результате их инфицирования собственными матерями. В настоящем исследовании изучена частота высеваемости <italic>S</italic><italic>. </italic><italic>agalactiae</italic> из мочи беременных при бессимптомной бактериурии с определением чувствительности выделенных штаммов к антибиотикам.</p> <p><bold>Цель исследования</bold> — изучение высеваемости стрептококка группы В при бессимптомной бактериурии беременных и определение чувствительности выделенных культур возбудителя к основным антибиотикам.</p> <p>Материалы м методы. В статье проведён анализ результатов бактериологических исследований 2559 образцов мочи от беременных. Мочу засевали на хромогенную среду UriSelect 4 Medium с последующей идентификацией <italic>S</italic><italic>. </italic><italic>agalactiae</italic> с помощью стрепто-латекс-теста либо CAMP-теста с культурой <italic>Staphylococcus</italic> <italic>aureus</italic> и определением чувствительности микроорганизмов к антибактериальным препаратам диско-диффузионным методом. Статистический анализ проводился на основе вычисления показателя χ<sup>2</sup> с применением программного пакета Statistica 12.0.</p> <p><bold>Результаты. </bold>Из исследуемых 2559 образцов мочи в 317 образцах (12,4%) выявлена бессимптомная бактериурия, изолировано 330 штаммов микроорганизмов. <italic>S</italic><italic>. </italic><italic>agalactiae</italic> выделен культуральным методом у 108 беременных (4,2% общего числа исследуемых), при этом в 50 случаях (16%) выявлена бессимптомная бактериурия, вызванная <italic>S</italic><italic>. </italic><italic>agalactiae</italic>. Показана высокая значимость <italic>Escherichia</italic> <italic>coli</italic> при бессимптомной бактериурии у беременных, в меньшей мере — <italic>Enterococcus</italic> spp. Обнаружены также ассоциации <italic>S</italic><italic>. </italic><italic>agalactiae</italic> с иными микроорганизмами. Продемонстрирована высокая чувствительность штаммов <italic>S</italic><italic>. </italic><italic>agalactiae</italic> к клиндамицину, в меньшей степени — к левофлоксацину, хлорамфениколу и особенно к эритромицину.</p> <p><bold>Заключение. </bold>Показана высокая высеваемость стрептококка группы B при бессимптомной бактериурии у беременных. Выявлена низкая чувствительность выделенных стрептококков к эритромицину, умеренная — к левофлоксацину и хлорамфениколу, высокая — к клиндамицину.</p></trans-abstract><kwd-group xml:lang="en"><kwd>group B streptococcus</kwd><kwd>asymptomatic bacteriuria</kwd><kwd>pregnant women</kwd><kwd>antibiotic sensitivity</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>стрептококк группы В</kwd><kwd>бессимптомная бактериурия</kwd><kwd>беременные</kwd><kwd>чувствительность к антибиотикам</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Morgan JA, Zafar N, Cooper DB. Group B Streptococcus and Pregnancy. StatPearls. Treasure Island: StatPearls Publishing; 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482443/.</mixed-citation><mixed-citation xml:lang="ru">Morgan J.A., Zafar N., Cooper D.B. Group B Streptococcus and Pregnancy // StatPearls. Treasure Island : StatPearls Publishing, 2023. Available at: https://www.ncbi.nlm.nih.gov/books/NBK482443/.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Naumkina EV, Abrosimova OA, Pakhalkova EV, Rogatykh NA, Mironov AYu. The infections induced by streptococcus of serogroup B in pregnant women, puerpera and newborns. Russian Clinical Laboratory Diagnostics. 2016;61(2):107–110. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Наумкина Е.В., Абросимова О.А., Пахалкова Е.В., Рогатых Н.А., Миронов А.Ю. Инфекции, вызванные стрептококком серогруппы В у беременных, родильниц и новорождённых // Клиническая лабораторная диагностика. 2016. Т. 61, № 2. С. 107–110.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Raabe VN, Shane AL. Group B Streptococcus (Streptococcus agalactiae). Microbiology Spectrum. 2019;7(2). doi: 10.1128/microbiolspec.GPP3-0007-2018</mixed-citation><mixed-citation xml:lang="ru">Raabe V.N., Shane A.L. Group B Streptococcus (Streptococcus agalactiae) // Microbiology Spectrum. 2019. Vol. 7, N 2. doi: 10.1128/microbiolspec.GPP3-0007-2018</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Shane AL, Sánchez PJ, Stoll BJ. Neonatal sepsis. The Lancet. 2017;390(10104):1770–1780. doi: 10.1016/S0140-6736(17)31002-4</mixed-citation><mixed-citation xml:lang="ru">Shane A.L. Sánchez P.J., Stoll B.J. Neonatal sepsis // The Lancet. 2017. Vol. 390, N 10104. P. 1770–1780. doi: 10.1016/S0140-6736(17)31002-4</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Dusmagambetova A, Dusmagambetov M, Zhunussov D, Zhussupov B. Prevalence of gram-positive cocci in the etiopathogenesis of asymptomatic bacteriuria of pregnant women in a five-year study. Astana Medicine Journals. 2021;(2(108)): 199–204. (In Russ).</mixed-citation><mixed-citation xml:lang="ru">Дусмагамбетова А.М., Дусмагамбетов М.У., Жунусов Д.К., Жусупов Б.З. Превалирование грамположительных кокков в этиопатогенезе бессимптомной бактериурии беременных в пятилетней динамике исследования // Астана мединалык журналы. 2021. № 2 (108). С. 199–204.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797. Obstetrics &amp; Gynecology. 2020;135(2):51–72. doi: 10.1097/AOG.0000000000003668</mixed-citation><mixed-citation xml:lang="ru">Prevention of Group B Streptococcal Early-Onset Disease in Newborns: ACOG Committee Opinion, Number 797 // Obstetrics &amp; Gynecology. 2020. Vol. 135, N 2. P. 51–72. doi: 10.1097/AOG.0000000000003668</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Nanduri SA, Petit S, Smelser C, et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance [preprint]. JAMA Pediatrics. 2019;173(3):224–233. doi: 10.1001/jamapediatrics.2018.4826</mixed-citation><mixed-citation xml:lang="ru">Nanduri S.A., Petit S., Smelser C., et al. Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015: multistate laboratory and population-based surveillance [preprint] // JAMA Pediatrics. 2019. Vol. 173, N 3. P. 224–233. doi: 10.1001/jamapediatrics.2018.4826</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Verani JR, McGee L, Schrag SJ. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR. Recommendations and Reports: Morbidity and mortality weekly report. Recommendations and reports. 2010;59(RR-10):1–36.</mixed-citation><mixed-citation xml:lang="ru">Verani J.R., McGee L., Schrag S.J. Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010 // MMWR. Recommendations and Reports: Morbidity and mortality weekly report. Recommendations and reports. 2010. Vol. 59, N RR-10. P. 1–36.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Shenoy ES, Macy E, Rowe Th, Blumenthal KG. Evaluation and Management of Penicillin Allergy: A Review. JAMA. 2019;321(2): 188–199. doi: 10.1001/jama.2018.19283</mixed-citation><mixed-citation xml:lang="ru">Shenoy E.S., Macy E., Rowe Th., Blumenthal K.G. Evaluation and Management of Penicillin Allergy: A Review // JAMA. 2019. Vol. 321, N 2. P. 188–199. doi: 10.1001/jama.2018.19283</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Chang LW, Garland SM, Daley AJ, Chean R. Increasing clindamycin resistance among Australian group B streptococcus isolates. Internal Medicine Journal. 2015;45(4):465–466. doi: 10.1111/imj.12720</mixed-citation><mixed-citation xml:lang="ru">Chang L.W., Garland S.M., Daley A.J., Chean R. Increasing clindamycin resistance among Australian group B streptococcus isolates // Internal Medicine Journal. 2015. Vol. 45, N 4. P. 465–466. doi: 10.1111/imj.12720</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Creti R, Imperi M, Berardi A, et al.; Italian Neonatal GBS Infections Working Group. Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance. Pediatr Infect Dis J. 2017;36(3):256–262. doi: 10.1097/INF.0000000000001414</mixed-citation><mixed-citation xml:lang="ru">Creti R., Imperi M., Berardi A., et al.; Italian Neonatal GBS Infections Working Group. Neonatal group B streptococcus infections: prevention strategies, clinical and microbiologic characteristics in 7 years of surveillance // Pediatr Infect Dis J. 2017. Vol. 36, N 3. P. 256–262. doi: 10.1097/INF.0000000000001414</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Teatero S, Ferrieri P, Martin I, et al. Serotype distribution, population structure, and antimicrobial resistance of group B streptococcus strains recovered from colonized pregnant women. J Clin Microbiol. 2017;55(2):412–422. doi: 10.1128/JCM.01615-16</mixed-citation><mixed-citation xml:lang="ru">Teatero S., Ferrieri P., Martin I., et al. Serotype distribution, population structure, and antimicrobial resistance of group B streptococcus strains recovered from colonized pregnant women // J Clin Microbiol. 2017. Vol. 55, N 2. P. 412–422. doi: 10.1128/JCM.01615-16</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Castor ML, Whitney CG, Como-Sabetti K, et al. Antibiotic resistance patterns in invasive group B streptococcal isolates. Infectious Diseases in Obstetrics and Gynecology. 2008;2008:1–5. doi: 10.1155/2008/727505</mixed-citation><mixed-citation xml:lang="ru">Castor M.L., Whitney C.G., Como-Sabetti K., et al. Antibiotic resistance patterns in invasive group B streptococcal isolates // Infectious Diseases in Obstetrics and Gynecology. 2008. Vol. 2008. P. 1–5. doi: 10.1155/2008/727505</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Mohamed AM, Khan MA, Faiz A, et al. Group B Streptococcus Colonization, Antibiotic Susceptibility, and Serotype Distribution among Saudi Pregnant Women. Infect Chemother. 2020;52(1):70–81. doi: 10.3947/ic.2020.52.1.70</mixed-citation><mixed-citation xml:lang="ru">Mohamed A.M., Khan M.A., Faiz A., et al. Group B Streptococcus Colonization, Antibiotic Susceptibility, and Serotype Distribution among Saudi Pregnant Women // Infect Chemother. 2020. Vol. 52, N 1. P. 70–81. doi: 10.3947/ic.2020.52.1.70</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">AlShamlan NA, AlOmar RS, Aldossary R, et al. The Epidemiology, Associated Factors and Bacterial Profile of Asymptomatic Bacteriuria in Pregnant Women: A Retrospective Chart Review Study in Saudi Arabia. International Journal of Women’s Health. 2022;14:1749–1759. doi: 10.2147/IJWH.S394936</mixed-citation><mixed-citation xml:lang="ru">AlShamlan N.A., AlOmar R.S., Aldossary R., et al. The Epidemiology, Associated Factors and Bacterial Profile of Asymptomatic Bacteriuria in Pregnant Women: A Retrospective Chart Review Study in Saudi Arabia // International Journal of Women’s Health. 2022. Vol. 14. P. 1749–1759. doi: 10.2147/IJWH.S394936</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Rosenberger KD, Seibert A, Hormig S. Asymptomatic GBS bacteriuria during antenatal visits: To treat or not to treat? The Nurse Practitioner. 2020;45(7):18–25. doi: 10.1097/01.NPR.0000669112.69022.aa</mixed-citation><mixed-citation xml:lang="ru">Rosenberger K.D., Seibert A., Hormig S. Asymptomatic GBS bacteriuria during antenatal visits: To treat or not to treat? // The Nurse Practitioner. 2020. Vol. 45, N 7. P. 18–25. doi: 10.1097/01.NPR.0000669112.69022.aa</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Do Nascimento CS, Dos Santos NFB, Ferreira RCC, Taddei CR. Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance. Brazilian Journal of Microbiology. 2019;50(4):943–952. doi: 10.1007/s42770-019-00129-8</mixed-citation><mixed-citation xml:lang="ru">Do Nascimento C.S., Dos Santos N.F.B., Ferreira R.C.C., Taddei C.R. Streptococcus agalactiae in pregnant women in Brazil: prevalence, serotypes, and antibiotic resistance // Brazilian Journal of Microbiology. 2019. Vol. 50, N 4. P. 943–952. doi: 10.1007/s42770-019-00129-8</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Muller AE, Valkenburg-van den Berg AW, Kreft D, et al. Low rate of carriage of macrolide-resistant group B streptococci in pregnant women in The Netherlands. European Journal of Obstetrics &amp; Gynecology and Reproductive Biology. 2008;137(1):17–20. doi: 10.1016/j.ejogrb.2007.04.001</mixed-citation><mixed-citation xml:lang="ru">Muller A.E., Valkenburg-van den Berg A.W., Kreft D., et al. Low rate of carriage of macrolide-resistant group B streptococci in pregnant women in The Netherlands // European Journal of Obstetrics &amp; Gynecology and Reproductive Biology. 2008. Vol. 137, N 1. P. 17–20. doi: 10.1016/j.ejogrb.2007.04.001</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Fröhlicher S, Reichen-Fahrni G, Müller M, et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Medical Weekly. 2014;144(1112):w13935. doi: 10.4414/smw.2014.13935</mixed-citation><mixed-citation xml:lang="ru">Fröhlicher S., Reichen-Fahrni G., Müller M., et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre // Swiss Medical Weekly. 2014. Vol. 144, N 1112. P. w13935. doi: 10.4414/smw.2014.13935</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Slotved HC, Møller JK, Khalil MR. The serotype distribution of Streptococcus agalactiae (GBS) carriage isolates among pregnant women having risk factors for early-onset GBS disease: a comparative study with GBS causing invasive infections during the same period in Denmark. BMC Infectious Diseases. 2021;21(1):1129. doi: 10.1186/s12879-021-06820-2</mixed-citation><mixed-citation xml:lang="ru">Slotved H.C., Møller J.K., Khalil M.R. The serotype distribution of Streptococcus agalactiae (GBS) carriage isolates among pregnant women having risk factors for early-onset GBS disease: a comparative study with GBS causing invasive infections during the same period in Denmark // BMC Infectious Diseases. 2021. Vol. 21, N 1. P. 1129. doi: 10.1186/s12879-021-06820-2</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Bae HG, Hong J, Kim Y-J, et al. A Retrospective National Study on Colonization Rate and Antimicrobial Susceptibility of Streptococcus agalactiae in Pregnant Korean Women. 2018–2020. Yonsei Medical Journal. 2022;63(8):717–723. doi: 10.3349/ymj.2022.63.8.717</mixed-citation><mixed-citation xml:lang="ru">Bae H.G., Hong J., Kim Y.-J., et al. A Retrospective National Study on Colonization Rate and Antimicrobial Susceptibility of Streptococcus agalactiae in Pregnant Korean Women. 2018–2020 // Yonsei Medical Journal. 2022. Vol. 63, N 8. P. 717–723. doi: 10.3349/ymj.2022.63.8.717</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Matani C, Trezzi M, Matteini A, et al. Streptococcus agalactiae: prevalence of antimicrobial resistance in vaginal and rectal swabs in Italian pregnant women. Le infezioni in medicina. 2016;24(3):217–221.</mixed-citation><mixed-citation xml:lang="ru">Matani C., Trezzi M., Matteini A., et al. Streptococcus agalactiae: prevalence of antimicrobial resistance in vaginal and rectal swabs in Italian pregnant women // Le infezioni in medicina. 2016. Vol. 24, N 3. P. 217–221.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Wang P, Tong JJ, Ma XH, et al. Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China. PloS One. 2015;10(3):e0120035. doi: 10.1371/journal.pone.0120035</mixed-citation><mixed-citation xml:lang="ru">Wang P., Tong J.J., Ma X.H., et al. Serotypes, antibiotic susceptibilities, and multi-locus sequence type profiles of Streptococcus agalactiae isolates circulating in Beijing, China // PloS One. 2015. Vol. 10, N 3. P. e0120035. doi: 10.1371/journal.pone.0120035</mixed-citation></citation-alternatives></ref></ref-list></back></article>
